Sign in

Filings

Finds words inside filing documents. Searching Aquestive Therapeutics, Inc.'s filings · 79 documents indexed.

37 documents · 60 matches

  1. AQST Aquestive Therapeutics, Inc. 10-Q 2025-05-12

    Item 1A. Risk Factors

    tariff. While pharmaceutical products are currently excluded from the baseline and "reciprocal" tariffs imposed by the United States, such tariffs
    5 matches in this document

  2. AQST Aquestive Therapeutics, Inc. 10-K 2026-03-04

    Item 1A. Risk Factors

    tariffs that vary by nation, product, or industry. Retaliatory tariffs on U.S. goods have been imposed by, among others, China
    6 matches in this document

  3. AQST Aquestive Therapeutics, Inc. 10-Q 2025-08-11

    Item 1A. Risk Factors

    tariffs imposed by the United States, such tariffs still apply to the raw materials and other products necessary for the manufacture
    5 matches in this document

  4. AQST Aquestive Therapeutics, Inc. 8-K 2026-11-03

    remains largely unaffected by government tariffs currently in effect. The Company continues to monitor proposed tariffs and other trade restrictions.
    1 match in this document

  5. AQST Aquestive Therapeutics, Inc. 8-K 2026-11-05

    tariffs and trade restrictions; and the other uncertainties described in the “Risk Factors” section and other sections of the Company
    1 match in this document

  6. AQST Aquestive Therapeutics, Inc. 10-Q 2026-11-03

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

  7. AQST Aquestive Therapeutics, Inc. 8-K 2026-09-25

    tariffs and trade restrictions; and the other uncertainties described in the “Risk Factors” section and other sections of the Company
    1 match in this document

  8. AQST Aquestive Therapeutics, Inc. 8-K 2026-09-17

    tariffs and trade restrictions; and the other uncertainties described in the “Risk Factors” section and other sections of the Company
    1 match in this document

  9. AQST Aquestive Therapeutics, Inc. 10-Q 2026-08-11

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

  10. AQST Aquestive Therapeutics, Inc. 8-K 2026-08-11

    both implemented and proposed government tariffs, providing continued reliability and stability in production and global distribution for the near term.
    3 matches in this document

  11. AQST Aquestive Therapeutics, Inc. 8-K 2026-08-11

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section included
    1 match in this document

  12. AQST Aquestive Therapeutics, Inc. 10-Q 2026-05-13

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

  13. AQST Aquestive Therapeutics, Inc. 8-K 2026-05-13

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

  14. AQST Aquestive Therapeutics, Inc. 8-K 2026-05-13

    both implemented and proposed government tariffs, providing continued reliability and stability in production and global distribution for the near term.
    3 matches in this document

  15. AQST Aquestive Therapeutics, Inc. 8-K 2026-03-30

    tariffs and other trade restrictions; and other risks and uncertainties affecting the Company described in the “Risk Factors” section and in other
    1 match in this document

  16. AQST Aquestive Therapeutics, Inc. 8-K 2026-03-04

    both implemented and proposed government tariffs, providing continued reliability and stability in production and global distribution for the near term.
    3 matches in this document

  17. AQST Aquestive Therapeutics, Inc. 8-K 2026-03-04

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

  18. AQST Aquestive Therapeutics, Inc. 8-K 2026-02-26

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

  19. AQST Aquestive Therapeutics, Inc. 8-K 2026-02-02

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

  20. AQST Aquestive Therapeutics, Inc. 8-K 2026-02-02

    tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other
    1 match in this document

Page 1 of 2 · 37 documents